Minerva Neurosciences | 销售和管理费用

股票价格
6.31
每天变化
0.66 11.68%
每月一次
46.06%
每年
225.26%
Q1 预测
2.46




销售和管理费用 更改 日
Acadia Pharmaceuticals USD 124.9M 1.24M 2025-09
Adma Biologics USD 23.05M 320K 2025-09
ALKERMES USD 171.77M 17.9M 2025-09
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
AstraZeneca USD 148M 4.86B 2025-09
BioCryst Pharmaceuticals USD 80.47M 15.39M 2024-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.33M 50K 2025-09
CSL USD 727M 453M 2025-06
Dynavax Technologies USD 40.09M 1.45M 2025-09
Eli Lilly USD 3.13B 391.3M 2025-12
Esperion Therapeutics USD 39.98M 4.21M 2024-09
GlaxoSmithKline GBP 2.68B 518M 2025-12
Grifols EUR 333.1M 157M 2025-09
Halozyme Therapeutics USD 37.53M 4.53M 2025-09
Ionis Pharmaceuticals USD 86.56M 4.04M 2025-09
J&J USD 6.75B 831M 2025-12
Merck USD 2.85B 215M 2025-12
Minerva Neurosciences USD 2.48M 58.79K 2024-09
Neurocrine Biosciences USD 291.6M 5.3M 2025-09
Novartis USD 3.31B 134M 2025-09
Novavax USD 66.95M 34.05M 2024-09
Pfizer USD 4.08B 894M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sanofi EUR 2.75B 455M 2025-12
Takeda JPY 282.78B 29.23B 2025-12
Vanda Pharmaceuticals USD 39.28M 1.71M 2024-12


Minerva Neurosciences 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.